Associated Papers
Mechanism of action of non-camptothecin inhibitor Genz-644282 in topoisomerase I inhibition.
Nishida M et al.
Communications Biology, 2022
New Topoisomerase I mutations are associated with resistance to camptothecin.
Gongora C et al.
Molecular Cancer, 2011
Topoisomerase I gene mutations at F270 in the large subunit and N184 in the small subunit contribute to the resistance mechanism of the unicellular parasite Leishmania donovani towards 3,3'-diindolylmethane.
Roy A et al.
Antimicrobial Agents and Chemotherapy, 2009
Effects of drug efflux proteins and topoisomerase I mutations on the camptothecin analogue gimatecan.
Gounder MK et al.
Investigational New Drugs, 2008
SR proteins as potential targets for therapy.
Soret J et al.
Progress in Molecular and Subcellular Biology, 2006
Effects of mutations in the F361 to R364 region of topoisomerase I (Topo I), in the presence and absence of 9-aminocamptothecin, on the Topo I-DNA interaction.
Pond CD et al.
Anti-cancer Drugs, 1999
Select a paper to view details